These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27474687)

  • 1. Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study.
    Marcus MM; Björkholm C; Malmerfelt A; Möller A; Påhlsson N; Konradsson-Geuken Å; Feltmann K; Jardemark K; Schilström B; Svensson TH
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1401-1411. PubMed ID: 27474687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
    Andreasen JT; Nielsen EØ; Christensen JK; Olsen GM; Peters D; Mirza NR; Redrobe JP
    J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats.
    Potasiewicz A; Hołuj M; Kos T; Popik P; Arias HR; Nikiforuk A
    Neuropharmacology; 2017 Feb; 113(Pt A):188-197. PubMed ID: 27717880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987.
    Andreasen JT; Redrobe JP; Nielsen EØ
    Pharmacol Biochem Behav; 2012 Jan; 100(3):624-9. PubMed ID: 22108649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α7 nicotinic receptor agonist and positive allosteric modulators differently improved schizophrenia-like cognitive deficits in male rats.
    Unal G; Sirvanci S; Aricioglu F
    Behav Brain Res; 2021 Jan; 397():112946. PubMed ID: 33011186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 7 nicotinic receptor agonist and positive allosteric modulators improved social and molecular deficits of MK-801 model of schizophrenia in rats.
    Unal G; Bekci H; Cumaoglu A; Yerer MB; Aricioglu F
    Pharmacol Biochem Behav; 2020 Jun; 193():172916. PubMed ID: 32220620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625.
    Marquis KL; Comery TA; Jow F; Navarra RL; Grauer SM; Pulicicchio C; Kelley C; Brennan JA; Roncarati R; Scali C; Haydar S; Ghiron C; Terstappen GC; Dunlop J
    Psychopharmacology (Berl); 2011 Dec; 218(4):635-47. PubMed ID: 21643676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.
    Nikiforuk A; Kos T; Hołuj M; Potasiewicz A; Popik P
    Neuropharmacology; 2016 Feb; 101():389-400. PubMed ID: 26232639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the α7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT₁a receptor antagonist.
    Pandya AA; Yakel JL
    Neuropharmacology; 2013 Jul; 70():35-42. PubMed ID: 23321689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat.
    Wadenberg MG; Manetti D; Romanelli MN; Arias HR
    Behav Brain Res; 2017 Aug; 333():129-134. PubMed ID: 28684359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.
    Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J
    Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive allosteric modulators of the α7 nicotinic acetylcholine receptor potentiate glutamate release in the prefrontal cortex of freely-moving rats.
    Bortz DM; Upton BA; Mikkelsen JD; Bruno JP
    Neuropharmacology; 2016 Dec; 111():78-91. PubMed ID: 27569994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.
    Jackson A; Papke RL; Damaj MI
    Psychopharmacology (Berl); 2018 Jul; 235(7):1897-1905. PubMed ID: 29549391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic α7 nicotinic acetylcholine receptors enhance hippocampal mossy fiber glutamatergic transmission via PKA activation.
    Cheng Q; Yakel JL
    J Neurosci; 2014 Jan; 34(1):124-33. PubMed ID: 24381273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats.
    Jones KM; McDonald IM; Bourin C; Olson RE; Bristow LJ; Easton A
    Psychopharmacology (Berl); 2014 Feb; 231(4):673-83. PubMed ID: 24057763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of inhibitory and excitatory effects of α7 nicotinic acetylcholine receptor activation in the prelimbic cortex regulates network activity and plasticity.
    Udakis M; Wright VL; Wonnacott S; Bailey CP
    Neuropharmacology; 2016 Jun; 105():618-629. PubMed ID: 26921769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive binding at a nicotinic receptor transmembrane site of two α7-selective positive allosteric modulators with differing effects on agonist-evoked desensitization.
    Collins T; Young GT; Millar NS
    Neuropharmacology; 2011 Dec; 61(8):1306-13. PubMed ID: 21820451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α7 nicotinic receptor full agonist reverse basolateral amygdala hyperactivity and attenuation of dopaminergic neuron activity in rats exposed to chronic mild stress.
    Neves GA; Grace AA
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1343-1353. PubMed ID: 31615702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha-7 nicotinic allosteric modulator PNU 120596 on depressive-like behavior after lipopolysaccharide administration in mice.
    Alzarea S; Rahman S
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():218-228. PubMed ID: 29800595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitation and inhibition of firing activity and N-methyl-D-aspartate-evoked responses of CA1 hippocampal pyramidal cells by alpha7 nicotinic acetylcholine receptor selective compounds in vivo.
    Bali ZK; Nagy LV; Budai D; Hernádi I
    Sci Rep; 2019 Jun; 9(1):9324. PubMed ID: 31249369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.